Can recurrences be predicted in craniopharyngiomas? β-catenin coexisting with stem cells markers and p-ATM in a clinicopathologic study of 45cases

Table 1 Clinicopathologic data

	Histotype^b	Gender	Age	β-catenin^a	CD133^a	CD166^a	Ki67	NpATM	CpATM	RT
1	adaprim	M	51	2 (1 × 2)	0	1(1 × 1)	2%	0	2	no
2	ada	M	61	0	0	0	3%	1	2	no
3	ada	F	13	1 (1 × 1)	1(1 × 1)	2(1 × 2)	2%	2	3	no
4	ada	F	2	2(1 × 2)	0	1(1 × 1)	10%	0	3	yes
5	ada	F	66	0	1(1 × 1)	0	2%	0	1	no
6	ada	M	9	0	0	0	1%	0	0	yes
7	adarec	M	9	9(3 × 3)	4(2 × 2)	4(2 × 2)	25%	1	0	yes
8	adarec	F	4	2(2 × 1)	3(3 × 1)	3(3 × 1)	--	0	2	yes
9	ada	F	15	1(1 × 1)	1(1 × 1)	1(1 × 1)	5%	1	1	no
10	paprec	M	58	0	0	2(1 × 2)	6%	2	2	no
11	adarec	M	63	6(2 × 3)	2(2 × 1)	6(3 × 2)	15%	0	2	yes
12	adarec	M	51	2(1 × 2)	4(2 × 2)	4(2 × 2)	5%	0	1	yes
13	pap	F	47	0	6(3 × 2)	4(2 × 2)	6%	3	0	yes
14	pap	M	57	0	4(2 × 2)	4(2 × 2)	5%	3	0	no
15	adaprim	M	67	4 (2 × 2)	3(3 × 1)	3(3 × 1)	10%	0	0	yes
16	ada	M	48	0	0	0	2%	0	1	yes
17	adarec	M	66	4(2 × 2)	2(2 × 1)	3(3 × 1)	7%	0	0	yes
18	ada	M	64	0	0	2(2 × 1)	3%	0	0	no
19	pap	M	27	0	4(2 × 2)	4(2 × 2)	--	2	0	no
20	ada	M	32	3(1 × 3)	1(1 × 1)	2(1 × 2)	2%	2	0	no
21	ada	M	57	2(2 × 1)	1(1 × 1)	0	3%	0	2	yes
22	ada	M	53	2(1 × 2)	0	1(1 × 1)	6%	2	0	yes
23	ada	F	43	2(2 × 1)	0	0	1%	3	2	yes
24	ada	F	36	0	--	0	5%	0	3	yes
25	adaprim	M	62	0	0	1(1 × 1)	15%	2	0	yes
26	ada	F	30	0	--	--	--	1	1	yes
27	adaprim	M	10	4(2 × 2)	0	4(2 × 2)	20%	2	2	no
28	ada	M	63	2(2 × 1)	--	--	20%	1	0	no
29	pap	M	49	0	0	2(1 × 2)	15%	2	0	no
30	adarec	F	12	4(2 × 2)	3(1 × 3)	4(2 × 2)	--	0	0	yes
31	ada	F	68	4(2 × 2)	0	6(3 × 2)	10%	1	3	no
32	ada	M	28	1 (1 × 1)	--	--	3%	2	0	yes
33	ada	M	77	0	--	--	2%	3	0	no
34	ada	F	52	0	--	--	4%	3	2	yes
35	adarec	M	12	3(1 × 3)	0	4(2 × 2)	10%	0	1	no
36	ada	M	59	1 (1 × 1)	--	--	18%	2	0	no
37	ada	M	45	2(1 × 2)	--	--	8%	1	0	no
38	pap	M	42	2(1 × 2)	--	--	3%	2	0	yes
39	ada	M	42	4(2 × 2)	--	--	6%	0	1	no
40	ada	F	76	6(3 × 2)	--	--	15%	3	0	no
41	ada	M	39	0	--	--	20%	0	2	no
42	pap	F	50	0	--	--	7%	1	0	yes
43	ada	M	58	6(2 × 3)	--	--	15%	0	1	no
44	adarec	M	21	4(2 × 2)	4(2 × 2)	3(1 × 3)	7%	1	0	yes
45	ada	F	54	2(1 × 2)	--	--	5%	3	1	no

^aImmunoscore = intensity score x proportion score; ^b ada prim is the primitive tumor whose recurrence was not inserted in this table; ada rec and pap rec are tissues from the recurrent tumor, whose primitive was not available. RT: radiotherapy

ISSN: 1756-9966